当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2012年第3期 > 正文
编号:12176548
调强放射治疗联合周剂量紫杉醇治疗食管癌的临床研究(3)
http://www.100md.com 2012年1月25日 谢朝辉 张斌 刘艳杰 黄微 展广宏 马永新 王薇
第1页
第7页

    参见附件。

     [3] Thomas R,Bortfeld P,Darren L,et al. X-ray field compensation with multileaf collimators [J]. International Journal of Radiation Oncology Biology Physics, 1994,28(3):723-730.

    [4] Mackie TR,Holmes TW,Reckwerdt PJ. Tomotherapy:optimized planning and delivery of radiation therapy [J]. International Journal of Imaging Systems and Technology,1995,6(1):43–55.

    [5] Miller AB,Hoogstratcn B,Staquet M,et al. Reporting result of cancer treatment [J]. Cancer,1981,47(1):207-214.

    [6] Kelson D. Chemotherapy of esophageal cancer [J]. Semin Oncol,1984,11(1):99.

    [7] 盛延兴,尹爱芹,张玉霞,等.食管癌全程连续后程加速超分割放疗的临床研究[J].实用癌症杂志,2007;22(1):88-90.

    [8] 谢朝辉.周剂量紫杉醇同步后程超分割放疗治疗24例食管癌[J].肿瘤学,2006,12(5):422-423.

    [9] Lorchel F,Dumas JL,Noёl A,et al. Esophageal cancer:determinnation of internal target volume for comformal radiotherapy [J]. Radiother Oncol,2006,80(3):327-332.

    [10] Vrieze O,Haustermans K,De Wever W,et al. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma [J]. Radiother Oncol,2004,73(3):269-275.

    [11] AI Sarraf U,Martz K,Herskovic A,et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer:an intergroup study [J]. J Clin Oncol,1997,15(1):277-284.

    [12] Seitz JF,Giovannini M,Padant CJ,et al. Inoperable nonmetastatic squamous cell carcinoma of the esophageal managed by concomitant chemotherapy (5-FU and DDP) and radiation therapy [J]. Cancer,1990,66(1):214.

    [13] Kok TC. Chemotherapy in esophageal cancer [J]. Cancer Tret Rev,1997,23(3):65-85.

    [14] Thomas E,Crellin A,Harris K,et al. The role of endoscopic ultrasound in planning radiotherapy target volumes for oesophageal [J]. Radiother Oncol,2004,73(2):149-151.

    (收稿日期:2011-11-01 本文编辑:徐娅楠)

您现在查看是摘要介绍页,详见PDF附件(3029kb)